Total Payments
$29,145
2024 Payments
$4,157
Companies
33
Transactions
1,799
Medicare Patients
1,014
Medicare Billing
$180,239
Payment Breakdown by Category
Food & Beverage$29,105 (99.9%)
Education$40.39 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,105 | 1,796 | 99.9% |
| Education | $40.39 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $3,376 | 247 | $0 (2022) |
| Allergan, Inc. | $3,278 | 186 | $0 (2020) |
| ABBVIE INC. | $3,237 | 151 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,739 | 162 | $0 (2024) |
| ITI, Inc. | $1,902 | 115 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,859 | 164 | $0 (2024) |
| Lundbeck LLC | $1,829 | 192 | $0 (2024) |
| Alkermes, Inc. | $1,734 | 67 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $1,543 | 72 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,345 | 72 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,157 | 227 | Alkermes, Inc. ($722.44) |
| 2023 | $3,417 | 169 | ABBVIE INC. ($816.00) |
| 2022 | $4,434 | 264 | ABBVIE INC. ($812.34) |
| 2021 | $4,536 | 316 | AbbVie Inc. ($1,132) |
| 2020 | $3,281 | 214 | Allergan, Inc. ($982.34) |
| 2019 | $3,240 | 202 | Allergan Inc. ($850.55) |
| 2018 | $3,385 | 221 | Allergan Inc. ($884.01) |
| 2017 | $2,696 | 186 | Sunovion Pharmaceuticals Inc. ($695.49) |
All Payment Transactions
1,799 individual payment records from CMS Open Payments — Page 1 of 72
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Central Nervous System | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $2.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: Central Nervous System | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: CNS | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $3.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $2.06 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $1.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $0.62 | General |
| Category: PSYCHIATRY | ||||||
| 11/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 265 | 739 | $100,530 | $42,428 |
| 2022 | 7 | 273 | 878 | $105,388 | $47,816 |
| 2021 | 7 | 233 | 1,003 | $101,605 | $54,291 |
| 2020 | 7 | 243 | 705 | $68,295 | $35,705 |
Total Patients
1,014
Total Services
3,325
Medicare Billing
$180,239
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 239 | $40,705 | $17,980 | 44.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 76 | 294 | $34,200 | $13,448 | 39.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 32 | 32 | $8,000 | $4,944 | 61.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 24 | 46 | $10,350 | $3,306 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 40 | $5,025 | $1,958 | 39.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 24 | 45 | $1,125 | $401.84 | 35.7% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2023 | 18 | 43 | $1,125 | $389.88 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 242 | $41,824 | $18,794 | 44.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 83 | 314 | $35,155 | $15,025 | 42.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 32 | 101 | $17,766 | $8,986 | 50.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 30 | 34 | $5,777 | $2,121 | 36.7% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 33 | 99 | $2,888 | $2,015 | 69.8% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2022 | 17 | 59 | $1,448 | $545.07 | 37.6% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 17 | 29 | $529.10 | $329.30 | 62.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 199 | $33,425 | $18,038 | 54.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 37 | 174 | $26,220 | $16,352 | 62.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 64 | 242 | $27,365 | $12,496 | 45.7% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 37 | 175 | $5,250 | $3,353 | 63.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $3,600 | $1,903 | 52.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 34 | 148 | $4,440 | $1,556 | 35.0% |
| 90785 | Interactive complexity | Office | 2021 | 12 | 53 | $1,305 | $594.41 | 45.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 59 | 179 | $26,850 | $13,177 | 49.1% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 62 | 236 | $23,300 | $12,380 | 53.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 33 | 90 | $9,000 | $5,505 | 61.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 16 | 16 | $4,150 | $1,731 | 41.7% |
About Dr. Gene Jacobs, D.O
Dr. Gene Jacobs, D.O is a Psychiatry healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699743245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gene Jacobs, D.O has received a total of $29,145 in payments from pharmaceutical and medical device companies, with $4,157 received in 2024. These payments were reported across 1,799 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($29,105).
As a Medicare-enrolled provider, Jacobs has provided services to 1,014 Medicare beneficiaries, totaling 3,325 services with total Medicare billing of $180,239. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Cranston, RI
- Active Since 03/09/2006
- Last Updated 12/18/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1699743245
Products in Payments
- VRAYLAR (Drug) $6,491
- LATUDA (Drug) $3,376
- REXULTI (Drug) $2,764
- CAPLYTA (Drug) $2,432
- INGREZZA (Drug) $1,345
- TRINTELLIX (Drug) $1,191
- LYBALVI (Drug) $1,011
- ABILIFY MAINTENA (Drug) $972.17
- Trintellix (Drug) $954.81
- HETLIOZ (Drug) $771.32
- ARISTADA (Drug) $723.91
- AUSTEDO (Drug) $643.52
- NUEDEXTA (Drug) $636.75
- Auvelity (Drug) $595.35
- BRINTELLIX (Drug) $534.66
- FANAPT (Drug) $512.57
- Qelbree (Drug) $474.11
- MYDAYIS (Drug) $407.71
- Dayvigo (Drug) $322.20
- VYVANSE (Drug) $259.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Cranston
Dr. Richard Miller, M.d, M.D
Psychiatry — Payments: $764,696
Psychiatry $764,696
Mark Zimmerman, Md, MD
Psychiatry — Payments: $218,647
Psychiatry $218,647
Robert Bessette, D.o, D.O
Psychiatry — Payments: $13,613
Psychiatry $13,613
Dr. John Ruggiano, M.d, M.D
Psychiatry — Payments: $10,571
Psychiatry $10,571
Dr. Maria Gonzalez, Md, MD
Psychiatry — Payments: $4,575
Psychiatry $4,575
Dr. Bruce Fischer, Md, MD
Psychiatry — Payments: $193.28
Psychiatry $193.28